 | • レポートコード：QY20ST-06767 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器・消耗品 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の経粘膜ドラッグデリバリ装置市場について種類別（頬側ルート、直腸ルート、経鼻ルート）、用途別（病院、住宅）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・経粘膜ドラッグデリバリ装置市場の概要 ・世界の主要地域別経粘膜ドラッグデリバリ装置市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の経粘膜ドラッグデリバリ装置市場規模2015-2026：種類別（頬側ルート、直腸ルート、経鼻ルート） ・世界の経粘膜ドラッグデリバリ装置市場規模2015-2026：用途別（病院、住宅） ・経粘膜ドラッグデリバリ装置の北米市場規模2015-2020 ・経粘膜ドラッグデリバリ装置のヨーロッパ市場規模2015-2020 ・経粘膜ドラッグデリバリ装置の中国市場規模2015-2020 ・経粘膜ドラッグデリバリ装置の日本市場規模2015-2020 ・経粘膜ドラッグデリバリ装置の東南アジア市場規模2015-2020 ・経粘膜ドラッグデリバリ装置のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・経粘膜ドラッグデリバリ装置の製造コスト分析 ・販売チャネル、流通業者、顧客 ・経粘膜ドラッグデリバリ装置の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Transmucosal Drug Delivery Devices Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Transmucosal Drug Delivery Devices market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Transmucosal Drug Delivery Devices market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Transmucosal Drug Delivery Devices industry.
Based on our recent survey, we have several different scenarios about the Transmucosal Drug Delivery Devices YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Transmucosal Drug Delivery Devices will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Transmucosal Drug Delivery Devices market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Transmucosal Drug Delivery Devices market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Transmucosal Drug Delivery Devices market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Transmucosal Drug Delivery Devices market. The report also includes nautical information, where it shows Transmucosal Drug Delivery Devices market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Transmucosal Drug Delivery Devices market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Transmucosal Drug Delivery Devices market.
Geographical Analysis:
Based on region, the global Transmucosal Drug Delivery Devices market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Transmucosal Drug Delivery Devices market are
Allergan
Amphastar Pharmaceuticals Inc
Aquestive Therapeutics Inc
ARS Pharmaceuticals
Combinent BioMedical Systems Inc
Aegis Therapeutics LLC
Bespak Europe Ltd
Callitas Therapeutics Inc
Segment by Type
Buccal Route
Rectal Route
Nasal Route
Segment by Application
Hospital
Residential
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Transmucosal Drug Delivery Devices market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Transmucosal Drug Delivery Devices market.
• The market share of the global Transmucosal Drug Delivery Devices market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Transmucosal Drug Delivery Devices market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Transmucosal Drug Delivery Devices market.
1 Transmucosal Drug Delivery Devices Market Overview
1.1 Transmucosal Drug Delivery Devices Product Scope
1.2 Transmucosal Drug Delivery Devices Segment by Type
1.2.1 Global Transmucosal Drug Delivery Devices Sales by Type (2020-2026)
1.2.2 Buccal Route
1.2.3 Rectal Route
1.2.4 Nasal Route
1.3 Transmucosal Drug Delivery Devices Segment by Application
1.3.1 Global Transmucosal Drug Delivery Devices Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Residential
1.4 Transmucosal Drug Delivery Devices Market Estimates and Forecasts (2015-2026)
1.4.1 Global Transmucosal Drug Delivery Devices Sales Growth Rate (2015-2026)
1.4.2 Global Transmucosal Drug Delivery Devices Revenue and Growth Rate (2015-2026)
1.4.3 Global Transmucosal Drug Delivery Devices Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Transmucosal Drug Delivery Devices Industry Impact
1.5.1 How the Covid-19 is Affecting the Transmucosal Drug Delivery Devices Industry
1.5.1.1 Transmucosal Drug Delivery Devices Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Transmucosal Drug Delivery Devices Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Transmucosal Drug Delivery Devices Players to Combat Covid-19 Impact
2 Transmucosal Drug Delivery Devices Estimate and Forecast by Region
2.1 Global Transmucosal Drug Delivery Devices Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Transmucosal Drug Delivery Devices Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2015-2020)
2.2.2 Global Transmucosal Drug Delivery Devices Revenue Market Share by Region (2015-2020)
2.3 Global Transmucosal Drug Delivery Devices Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Transmucosal Drug Delivery Devices Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Transmucosal Drug Delivery Devices Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Transmucosal Drug Delivery Devices Estimates and Projections (2015-2026)
2.4.2 Europe Transmucosal Drug Delivery Devices Estimates and Projections (2015-2026)
2.4.3 China Transmucosal Drug Delivery Devices Estimates and Projections (2015-2026)
2.4.4 Japan Transmucosal Drug Delivery Devices Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Transmucosal Drug Delivery Devices Estimates and Projections (2015-2026)
2.4.6 India Transmucosal Drug Delivery Devices Estimates and Projections (2015-2026)
3 Global Transmucosal Drug Delivery Devices Competition Landscape by Players
3.1 Global Top Transmucosal Drug Delivery Devices Players by Sales (2015-2020)
3.2 Global Top Transmucosal Drug Delivery Devices Players by Revenue (2015-2020)
3.3 Global Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery Devices as of 2019)
3.4 Global Transmucosal Drug Delivery Devices Average Price by Company (2015-2020)
3.5 Manufacturers Transmucosal Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Transmucosal Drug Delivery Devices Players (Opinion Leaders)
4 Global Transmucosal Drug Delivery Devices Market Size by Type
4.1 Global Transmucosal Drug Delivery Devices Historic Market Review by Type (2015-2020)
4.1.1 Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
4.1.2 Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2015-2020)
4.1.3 Global Transmucosal Drug Delivery Devices Price by Type (2014-2020)
4.2 Global Transmucosal Drug Delivery Devices Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Transmucosal Drug Delivery Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Transmucosal Drug Delivery Devices Revenue Forecast by Type (2021-2026)
4.2.3 Global Transmucosal Drug Delivery Devices Price Forecast by Type (2021-2026)
5 Global Transmucosal Drug Delivery Devices Market Size by Application
5.1 Global Transmucosal Drug Delivery Devices Historic Market Review by Application (2015-2020)
5.1.1 Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
5.1.2 Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2015-2020)
5.1.3 Global Transmucosal Drug Delivery Devices Price by Application (2015-2020)
5.2 Global Transmucosal Drug Delivery Devices Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Transmucosal Drug Delivery Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Transmucosal Drug Delivery Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Transmucosal Drug Delivery Devices Price Forecast by Application (2021-2026)
3 North America Transmucosal Drug Delivery Devices Market Facts & Figures
3.2 North America Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
3.3 North America Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
3.4 North America Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
4 Europe Transmucosal Drug Delivery Devices Market Facts & Figures
4.2 Europe Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
4.3 Europe Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
4.4 Europe Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
5 China Transmucosal Drug Delivery Devices Market Facts & Figures
5.2 China Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
5.3 China Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
5.4 China Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
6 Japan Transmucosal Drug Delivery Devices Market Facts & Figures
6.2 Japan Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
6.3 Japan Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
6.4 Japan Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
7 Southeast Asia Transmucosal Drug Delivery Devices Market Facts & Figures
7.2 Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
8 India Transmucosal Drug Delivery Devices Market Facts & Figures
8.2 India Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
8.3 India Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
8.4 India Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Transmucosal Drug Delivery Devices Business
12.1 Allergan
12.1.1 Allergan Transmucosal Drug Delivery Devices Corporation Information
12.1.2 Allergan Transmucosal Drug Delivery Devices Business Overview and Total Revenue
12.1.3 Allergan Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Transmucosal Drug Delivery Devices Products Offered
12.1.5 Allergan Recent Development
12.2 Amphastar Pharmaceuticals Inc
12.2.1 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Corporation Information
12.2.2 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Business Overview and Total Revenue
12.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Products Offered
12.2.5 Amphastar Pharmaceuticals Inc Recent Development
12.3 Aquestive Therapeutics Inc
12.3.1 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Corporation Information
12.3.2 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Business Overview and Total Revenue
12.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Products Offered
12.3.5 Aquestive Therapeutics Inc Recent Development
12.4 ARS Pharmaceuticals
12.4.1 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Corporation Information
12.4.2 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Business Overview and Total Revenue
12.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2015-2020)
12.4.4 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Products Offered
12.4.5 ARS Pharmaceuticals Recent Development
12.5 Combinent BioMedical Systems Inc
12.5.1 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Corporation Information
12.5.2 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Business Overview and Total Revenue
12.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Products Offered
12.5.5 Combinent BioMedical Systems Inc Recent Development
12.6 Aegis Therapeutics LLC
12.6.1 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Corporation Information
12.6.2 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Business Overview and Total Revenue
12.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Products Offered
12.6.5 Aegis Therapeutics LLC Recent Development
12.7 Bespak Europe Ltd
12.7.1 Bespak Europe Ltd Transmucosal Drug Delivery Devices Corporation Information
12.7.2 Bespak Europe Ltd Transmucosal Drug Delivery Devices Business Overview and Total Revenue
12.7.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bespak Europe Ltd Transmucosal Drug Delivery Devices Products Offered
12.7.5 Bespak Europe Ltd Recent Development
12.8 Callitas Therapeutics Inc
12.8.1 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Corporation Information
12.8.2 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Business Overview and Total Revenue
12.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Products Offered
12.8.5 Callitas Therapeutics Inc Recent Development
13 Transmucosal Drug Delivery Devices Manufacturing Cost Analysis
13.1 Transmucosal Drug Delivery Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Transmucosal Drug Delivery Devices
13.4 Transmucosal Drug Delivery Devices Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Transmucosal Drug Delivery Devices Distributors List
14.3 Transmucosal Drug Delivery Devices Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Transmucosal Drug Delivery Devices Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Transmucosal Drug Delivery Devices Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Transmucosal Drug Delivery Devices Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Transmucosal Drug Delivery Devices Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Transmucosal Drug Delivery Devices Players to Combat Covid-19 Impact
Table 8. Global Market Transmucosal Drug Delivery Devices Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Transmucosal Drug Delivery Devices Sales (K Units) by Region (2015-2020)
Table 10. Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2015-2020)
Table 11. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Transmucosal Drug Delivery Devices Revenue Share by Region (2015-2020)
Table 13. Global Transmucosal Drug Delivery Devices Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Transmucosal Drug Delivery Devices Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Transmucosal Drug Delivery Devices Revenue Share Forecast by Region (2021-2026)
Table 17. Global Transmucosal Drug Delivery Devices (K Units) of Key Companies (2015-2020)
Table 18. Global Transmucosal Drug Delivery Devices Sales Share by Company (2015-2020)
Table 19. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Transmucosal Drug Delivery Devices Revenue Share by Company (2015-2020)
Table 21. Global Transmucosal Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery Devices as of 2019)
Table 22. Global Transmucosal Drug Delivery Devices Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Transmucosal Drug Delivery Devices Manufacturing Sites and Area Served
Table 24. Manufacturers Transmucosal Drug Delivery Devices Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Transmucosal Drug Delivery Devices Players
Table 27. Global Transmucosal Drug Delivery Devices Sales (K Units) by Type (2015-2020)
Table 28. Global Transmucosal Drug Delivery Devices Sales Share by Type (2015-2020)
Table 29. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Transmucosal Drug Delivery Devices Price (K Units) by Type (2015-2020)
Table 31. Global Transmucosal Drug Delivery Devices Sales Share by Type (2021-2026)
Table 32. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Transmucosal Drug Delivery Devices Revenue Share by Type (2021-2026)
Table 34. Global Transmucosal Drug Delivery Devices Price (K Units) by Type (2021-2026)
Table 35. Global Transmucosal Drug Delivery Devices Sales (K Units) by Application (2015-2020)
Table 36. Global Transmucosal Drug Delivery Devices Sales Share by Application (2015-2020)
Table 37. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Transmucosal Drug Delivery Devices Price (K Units) by Application (2015-2020)
Table 39. Global Transmucosal Drug Delivery Devices Sales (K Units) by Application (2021-2026)
Table 40. Global Transmucosal Drug Delivery Devices Sales Share by Application (2021-2026)
Table 41. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Transmucosal Drug Delivery Devices Revenue Share by Application (2021-2026)
Table 43. Global Transmucosal Drug Delivery Devices Price (K Units) by Application (2021-2026)
Table 44. United States Transmucosal Drug Delivery Devices Sales (K Units) by Company (2015-2020)
Table 45. United States Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
Table 46. United States Transmucosal Drug Delivery Devices Sales (K Units) by Type (2015-2020)
Table 47. United States Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
Table 48. United States Transmucosal Drug Delivery Devices Sales (K Units) by Application (2015-2020)
Table 49. United States Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
Table 50. Europe Transmucosal Drug Delivery Devices Sales (K Units) by Company (2015-2020)
Table 51. Europe Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
Table 52. Europe Transmucosal Drug Delivery Devices Sales (K Units) by Type (2015-2020)
Table 53. Europe Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
Table 54. Europe Transmucosal Drug Delivery Devices Sales (K Units) by Application (2015-2020)
Table 55. Europe Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
Table 56. China Transmucosal Drug Delivery Devices Sales (K Units) by Company (2015-2020)
Table 57. China Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
Table 58. China Transmucosal Drug Delivery Devices Sales (K Units) by Type (2015-2020)
Table 59. China Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
Table 60. China Transmucosal Drug Delivery Devices Sales (K Units) by Application (2015-2020)
Table 61. China Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
Table 62. Japan Transmucosal Drug Delivery Devices Sales (K Units) by Company (2015-2020)
Table 63. Japan Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
Table 64. Japan Transmucosal Drug Delivery Devices Sales (K Units) by Type (2015-2020)
Table 65. Japan Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
Table 66. Japan Transmucosal Drug Delivery Devices Sales (K Units) by Application (2015-2020)
Table 67. Japan Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Transmucosal Drug Delivery Devices Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Transmucosal Drug Delivery Devices Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Transmucosal Drug Delivery Devices Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
Table 74. India Transmucosal Drug Delivery Devices Sales (K Units) by Company (2015-2020)
Table 75. India Transmucosal Drug Delivery Devices Sales Market Share by Company (2015-2020)
Table 76. India Transmucosal Drug Delivery Devices Sales (K Units) by Type (2015-2020)
Table 77. India Transmucosal Drug Delivery Devices Sales Market Share by Type (2015-2020)
Table 78. India Transmucosal Drug Delivery Devices Sales (K Units) by Application (2015-2020)
Table 79. India Transmucosal Drug Delivery Devices Sales Market Share by Application (2015-2020)
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Transmucosal Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Allergan Transmucosal Drug Delivery Devices Product
Table 84. Allergan Recent Development
Table 85. Amphastar Pharmaceuticals Inc Corporation Information
Table 86. Amphastar Pharmaceuticals Inc Description and Business Overview
Table 87. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product
Table 89. Amphastar Pharmaceuticals Inc Recent Development
Table 90. Aquestive Therapeutics Inc Corporation Information
Table 91. Aquestive Therapeutics Inc Description and Business Overview
Table 92. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product
Table 94. Aquestive Therapeutics Inc Recent Development
Table 95. ARS Pharmaceuticals Corporation Information
Table 96. ARS Pharmaceuticals Description and Business Overview
Table 97. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product
Table 99. ARS Pharmaceuticals Recent Development
Table 100. Combinent BioMedical Systems Inc Corporation Information
Table 101. Combinent BioMedical Systems Inc Description and Business Overview
Table 102. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product
Table 104. Combinent BioMedical Systems Inc Recent Development
Table 105. Aegis Therapeutics LLC Corporation Information
Table 106. Aegis Therapeutics LLC Description and Business Overview
Table 107. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product
Table 109. Aegis Therapeutics LLC Recent Development
Table 110. Bespak Europe Ltd Corporation Information
Table 111. Bespak Europe Ltd Description and Business Overview
Table 112. Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Bespak Europe Ltd Transmucosal Drug Delivery Devices Product
Table 114. Bespak Europe Ltd Recent Development
Table . Callitas Therapeutics Inc Corporation Information
Table . Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Callitas Therapeutics Inc Description and Business Overview
Table . Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product
Table . Callitas Therapeutics Inc Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Transmucosal Drug Delivery Devices Distributors List
Table 123. Transmucosal Drug Delivery Devices Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Transmucosal Drug Delivery Devices Product Picture
Figure 2. Global Transmucosal Drug Delivery Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Transmucosal Drug Delivery Devices Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Residential Examples
Figure 8. Global Transmucosal Drug Delivery Devices Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Transmucosal Drug Delivery Devices Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Transmucosal Drug Delivery Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Transmucosal Drug Delivery Devices Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Transmucosal Drug Delivery Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Transmucosal Drug Delivery Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Transmucosal Drug Delivery Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Transmucosal Drug Delivery Devices Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Transmucosal Drug Delivery Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Transmucosal Drug Delivery Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Transmucosal Drug Delivery Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Transmucosal Drug Delivery Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Transmucosal Drug Delivery Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Transmucosal Drug Delivery Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Transmucosal Drug Delivery Devices Players Market Share by Revenue in Transmucosal Drug Delivery Devices 2015 & 2019
Figure 26. Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Transmucosal Drug Delivery Devices Revenue Share by Type (2015-2020)
Figure 28. Global Transmucosal Drug Delivery Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Transmucosal Drug Delivery Devices Revenue Share by Application (2015-2020)
Figure 30. Global Transmucosal Drug Delivery Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Transmucosal Drug Delivery Devices Sales Market Share by Type in 2019
Figure 32. United States Transmucosal Drug Delivery Devices Sales Market Share by Type in 2019
Figure 33. Europe Transmucosal Drug Delivery Devices Sales Market Share by Company in 2019
Figure 34. Europe Transmucosal Drug Delivery Devices Sales Market Share by Type in 2019
Figure 35. Europe Transmucosal Drug Delivery Devices Sales Market Share by Application in 2019
Figure 36. China Transmucosal Drug Delivery Devices Sales Market Share by Company in 2019
Figure 37. China Transmucosal Drug Delivery Devices Sales Market Share by Type in 2019
Figure 38. China Transmucosal Drug Delivery Devices Sales Market Share by Application in 2019
Figure 39. Japan Transmucosal Drug Delivery Devices Sales Market Share by Company in 2019
Figure 40. Japan Transmucosal Drug Delivery Devices Sales Market Share by Type in 2019
Figure 41. Japan Transmucosal Drug Delivery Devices Sales Market Share by Application in 2019
Figure 42. Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Company in 2019
Figure 43. Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Type in 2019
Figure 44. Southeast Asia Transmucosal Drug Delivery Devices Sales Market Share by Application in 2019
Figure 45. India Transmucosal Drug Delivery Devices Sales Market Share by Company in 2019
Figure 46. India Transmucosal Drug Delivery Devices Sales Market Share by Type in 2019
Figure 47. India Transmucosal Drug Delivery Devices Sales Market Share by Application in 2019
Figure 48. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Amphastar Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Aquestive Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. ARS Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Combinent BioMedical Systems Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Aegis Therapeutics LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Bespak Europe Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Callitas Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Transmucosal Drug Delivery Devices
Figure 58. Manufacturing Process Analysis of Transmucosal Drug Delivery Devices
Figure 59. Transmucosal Drug Delivery Devices Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
経鼻ドラッグデリバリーデバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nasal Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nasal Drug Delive…- ドラッグデリバリーデバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 結腸標的薬物送達の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Colon Targeting Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 結腸標的薬物送達の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Colon Targeting Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 非侵襲性ドラッグデリバリーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Non-Invasive Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…